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Abstract 
 
Objective: To describe a sample that received human rabies postexposure prophylaxis (PEP) in 
Virginia as a result of animal exposures in 2002 and 2003 and to determine the extent to which 
PEP decisions were appropriate. 
 
Methods: PEP surveillance data were requested from 35 Virginia health districts within 5 
regions. Retrospective chart review was used to gather demographic, exposure and source animal 
data from patient records and animal exposure reports. Descriptive statistics are presented. True 
exposures and appropriateness of PEP were defined using the 2004 Virginia Rabies Control 
Guidelines and the Recommendations of the 1999 Advisory Committee on Immunization 
Practices. The 2003 sample was analyzed for appropriateness of PEP because it was more 
representative than the 2002 sample. Stepwise syntax was created in SPSS utilizing 3 key 
decision variables and the 2004 Virginia Rabies Control Guidelines Algorithm for PEP decisions 
to determine appropriateness of PEP.  
 
Results: The 2002 and 2003 sample consisted of 838 PEP records, (73.6%) of 1139 PEP 
reported to the Division of Zoonotic and Environmental Epidemiology (central office of the 
Virginia Department of Health). Most PEP patients were young (mean 32.3 years) and had true 
exposures during spring or summer that resulted from approaching and handling a potentially 
rabid animal. Over half of the source animals were not captured. For the analysis of 
appropriateness, 55.2% (270/489) of PEP was appropriate, 22.5% (110/489) was inappropriate 
and 22.3% (109/489) of PEP had missing data on key decision variables. Inappropriate PEP 
primarily resulted from not true exposures [79% (87/110)]. Group exposures represented 42% 
more inappropriate PEP than individual exposures. 
 
Conclusion: Much PEP could be avoided in Virginia if more source animals were captured. The 
majority of inappropriate PEP occurred because PEP was given for exposures that were not true. 
New educational strategies for health care providers, public health personnel and the public are 
recommended to reduce the number of inappropriate PEP. Standardization of data collection 
methods, linking human and source animal data, computerization and formation of a central 
database are recommended to improve human rabies PEP surveillance in Virginia 
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Introduction 
 
     Infection with the rabies virus can lead to encephalitis and death in humans. In the United 
States, rabies is a rare human disease. Although it is considered invariably fatal once symptoms 
develop, six recoveries from rabies infection have been reported, three in the United States.1   
Most recently, in 2004, a 15 year old female developed symptoms of rabies after being bitten by 
a rabid bat and became the first unvaccinated patient documented to recover from clinical rabies 
infection.1 Rabies can be prevented if postexposure prophylaxis (PEP) is given in a timely and 
appropriate manner.2-3 Careful evaluation of rabies exposures and appropriate decisions about 
human rabies postexposure prophylaxis (PEP) treatment are critical not only to the prevention of 
human rabies fatalities but also to avoid unnecessary administration of rabies PEP to those not 
truly exposed.  Local health departments, health care providers and especially ED physicians 
must have ready access to and a working knowledge of the guidelines for rabies postexposure 
prophylaxis described in the 1999 Recommendations of the Advisory Committee on 
Immunization Practices (ACIP) to make appropriate decisions about administration of PEP.3  
Effective communication between health care providers and rabies experts at local and state 
health departments is necessary for accurate initial assessment of rabies exposures, assurance 
that exposing animals are properly managed, and appropriate and timely decisions to administer 
PEP or avoidance of unnecessary PEP.3-6  The PEP treatment regimen requires a previously 
unvaccinated (rabies naïve) exposed person to receive Human Rabies Immune Globulin (HRIG) 
injections (20 IU/kg) in and around the wound site on day 0 and to receive five intramuscular 
injections of rabies vaccine (days 0, 3, 7, 14 and 28).3  Previously vaccinated persons (those that 
have received preexposure or postexposure regimens of Human Diploid Cell Vaccine (HDCV), 
Rabies Vaccine Adsorbed (RVA) or Purified Chick Embryo Cell Vaccine (PCEC) or have a 
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documented rabies titer) receive two IM doses of rabies vaccine (Day 0, and Day 3) after an 
exposure.3 
     Human rabies PEP is expensive, time-consuming, labor intensive, carries risk for adverse 
reactions and rabies biologics are often in short supply.3-4, 7-8  In the United States, an estimated  
40,000 people receive rabies PEP annually at a 1998 estimated per-patient cost range of $1,038 
to 4,447 for a complete PEP regimen including physician and emergency department (ED) 
charges.2,9-11 The first treatment is the most expensive part of the regimen, because both HRIG 
and rabies vaccine are given, emphasizing the importance of evaluating exposures carefully and 
treating appropriately when the patient is first presented for medical attention.8-10   
     On April 2, 2004 Aventis Pasteur, producer of IMOVAX® Rabies Human Diploid Cell 
Vaccine (HDCV) and one of only two pharmaceutical companies producing rabies vaccine for 
the United States issued a recall of several lots of their rabies vaccine and later halted production 
and distribution entirely, leaving only one manufacturer, Chiron, to supply rabies vaccine 
internationally.12 The prospective for a limited supply of rabies vaccine further emphasizes the 
importance of evaluating each potential rabies exposure carefully and appropriately 
administering PEP according to the 1999 Recommendations of the Advisory Committee on 
Immunization Practices (ACIP) guidelines.3 
     Virginia’s Regulations for Disease Reporting and Control, as of July 2004, requires 
physicians and directors of medical care facilities to report human rabies postexposure 
prophylaxis to local health departments within three days.13-14 Local health departments (LHDs) 
in Virginia reported to the Office of Epidemiology of the Virginia Department of Health that   
586 courses of PEP were given in 2002 and 553 courses were given in 2003 by the LHDs or by 
private health care providers (Suzanne R. Jenkins, September 2004). PEP is indicated, according 
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to the 1999 ACIP recommendations and 2004 Virginia Rabies Control Guidelines, when a 
human is potentially exposed to rabies virus in any of the following circumstances defined as a 
true exposure: “any bite, scratch or other situation where saliva or central nervous system (CNS) 
tissue of a potentially rabid animal [that is not available for testing] enters an open, fresh wound 
or comes in contact with a mucous membrane by entering the eye, mouth or nose.”3,15 Touching 
or handling of a potentially rabid animal or an animal or inanimate object that had contact with a 
rabid animal does not constitute a true exposure and is a questionable exposure unless wet saliva 
or CNS material from the rabid animal enters a fresh, open wound or contacts a mucous 
membrane.15 Evaluation of potential rabies exposures resulting from bats is more difficult than 
terrestrial mammals because transmission of rabies from rabid bats to humans can occur with 
little historical evidence of exposure. Bites from the tiny teeth of bats inflict such minor tissue 
damage that they may easily go unnoticed making exposure documentation particularly 
problematic.3 According to the 1999 ACIP recommendations for bat exposures, 
Rabies postexposure prophylaxis is recommended for all persons with bite, scratch, or 
mucous membrane exposure to a bat, unless the bat is available for testing and is negative 
for evidence of rabies. Postexposure prophylaxis might be appropriate even if a bite, 
scratch, or mucous membrane exposure is not apparent when there is reasonable 
probability that such exposure might have occurred. Postexposure should be considered 
when direct contact between a human and a bat has occurred, unless the exposed person 
can be certain a bite, scratch, or mucous membrane exposure did not occur. In instances 
in which a bat is found indoors and there is no history of bat-human contact, the likely 
effectiveness of postexposure prophylaxis must be balanced against the low risk such 
exposures appear to present. In this setting, postexposure prophylaxis can be considered 
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for persons who were n the same room as the bat and who might be unaware that a bite or 
direct contact had occurred (e.g., a sleeping person awakens to find a bat in the room or 
an adult witnesses a bat in the room with a previously unattended child, mentally disabled 
person or intoxicated person) and rabies cannot be ruled out by testing the bat. 
Postexposure prophylaxis would not be warranted for other household members. (p. 9) 3 
     Rabies virus is enzootic in certain Virginia wildlife species and human exposures to 
confirmed or potentially rabid animals continue to occur on a regular basis.16 In 2003, 542 cases 
of animal rabies were reported in Virginia, 90% in wild animals (raccoons, skunks, bats and 
foxes) and 10% in domestic animals (cats, dogs and cattle).16 Species are categorized as high risk 
or low risk based upon the incidence of rabies infection in the species and what is known about 
rabies transmission to humans in the particular species. In Virginia high risk wildlife species 
include foxes, skunks, raccoons, groundhogs or woodchucks, bats, beavers and opossums, and 
these animals are considered rabid unless proven negative by laboratory testing.15 
     PEP is indicated within the first 24 hours following a true exposure to a high risk wildlife 
species that is unavailable for testing.3,16   It is appropriate to delay PEP for several days after a 
true exposure to a high risk domestic species (dogs, cats and ferrets) pending capture of the 
animal. PEP is indicated if the source animal remains uncaptured (stray) the third day after 
exposure.16 Dogs, cats or ferrets that are collected and initially appear normal are confined for 
ten days to observe for signs of rabies.16 If during the ten day confinement the animal sickens or 
dies, escapes, is euthanized or tests positive for rabies then PEP becomes appropriate.16 Wild 
animal hybrids, the offspring of wild animals crossbred to domestic species (cats or dogs), are 
considered wild animals by the National Association of State and Public Health Veterinarians 
(NASPHV) and the Council of State and Territorial Epidemiologists (CSTE).3 The ACIP 
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recommends that postexposure management for those animals be the same as for wild animals.3  
Wild animal hybrids have unknown incubation periods for rabies, unknown duration of rabies 
virus shedding and rabies vaccines are not licensed for use in these animals.3 Wolf hybrids are 
more commonly encountered than other wild animal hybrids in Virginia. Virginia follows the 
recommendations of the 2005 Compendium of Animal Rabies Prevention and Control regarding 
PEP for bites by wolf hybrids, e.g. it is determined on a case by case basis.2   Euthanasia and 
testing of wolf hybrids that bite humans is pursued if victims and their physicians request it. 
     Low risk animal species in Virginia include small rodents, rabbits, squirrels and non-human 
primates among wild species and cattle, horses, goats, sheep, pigs and humans among domestic 
species. Low risk species are not considered a risk for rabies transmission unless their behavior is 
abnormal or aggressive or they are confirmed rabid.15  
     Beginning in 1980 more immunogenic modern cell culture rabies vaccines with fewer side 
effects than the duck embryo vaccine were introduced in the United States (Merieux HDCV in 
June 1980 and Chiron Purified Chick Embryo Cell vaccine (PCECV) FDA approved for use in 
1997).4,17 Several studies both internationally and in the United States investigated the 
epidemiology and appropriateness of human rabies PEP after the introduction of these new 
vaccines.4-7,18-25  A pilot program for the Merieux HDVC vaccine licensed in June1980 expanded 
into a large, multi-state surveillance of PEP.4   Helmick, in a twenty-one state (1980 -1981) 
descriptive surveillance study of  5,654 PEP cases in civilian populations, determined that when 
state health departments were involved in decision-making and administration using exposure 
definitions similar to ACIP guidelines, PEP was started and given appropriately to 88% of the 
persons.3-4 Only states with 80% estimated completeness of reporting of HDCV PEP were 
included in the study.  Helmick found that states with a long history of consultation between 
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state health departments and physicians (Georgia and Illinois) had a lower incidence of PEP than 
most other comparable states when classified by similar rabid species.4 In the Helmick study, 
wild animal exposures represented only 33% of PEP given, yet represented 87% of proven rabid 
animals, and domestic animal exposures (dogs and cats) overrepresented PEP given in relation to 
their small role in animal rabies.4 According to Helmick, 40% of PEP resulted from non-bite 
exposures, many part of large group exposures to a single animal; PEP that might have been 
avoided with more careful interviewing.4 
     A 1982 – 1983 descriptive epidemiological study of the raccoon rabies epizootic in Middle 
Atlantic States (Virginia, Maryland, and District of Columbia), a collaboration between local 
health departments and the CDC, concluded that of 133 persons who received rabies PEP 
resulting from exposure to wild animals (raccoons, foxes or skunks), 50% received PEP for 
questionable exposures.18 Questionable exposures included touching rabid or potentially rabid 
animals and indirect contact through handling fomites or an animal that had contact with a rabid 
animal, exposures considered (then and now) to convey minimal or no risk according to ACIP 
guidelines.3,18  This study was limited by possible non-response and selection bias. Sampling was 
not random but voluntary, and over 98% of the data from the study was limited to six counties 
and one city, although 22 counties and cities were queried.18 Data sources retrieved through 
personal accounts and retrospective review of records were often incomplete, inconsistent and 
may have introduced recall bias.18    
      A 4000% increase in human rabies PEP in New York, from 81 cases in 1989 to 3,336 cases 
in 1993, has been attributed to the spread of the Mid-Atlantic raccoon rabies epizootic into New 
York in 1990.24 Rabid animals increased in New York from 54 in 1989 to 2746 (89% raccoons) 
in 1993.24 In response to these analyses and the Healthy People 2000 objective to reduce by 50% 
       
  
  
  
 7
the need for human rabies PEP by the year 2000, an epidemiological study was conducted of all 
human rabies PEP reported in four upstate New York counties, 1993 and 1994.24, 26 Of 1,173 
cases of PEP reported, 70% (817) resulted from non-bite exposures, predominantly indirect 
exposure to saliva on animal or fomites.24 
     A telephone survey of 28 local Kentucky health departments that reviewed PEP patient 
records, found that of 97 patients that received PEP in 1994, 18 (18.6%) of the exposures were 
from scratches, licks or other non-bite exposures, 71 (73.2%) exposures resulted from bites and 8 
(8.2%) were unknown. Domestic animal exposures represented 80 (82.5%) of the 97 PEP 
treatments.23 The researchers found that 83 (77.1%) of the animals were not available for 
observation and testing and concluded that the incidents were not appropriately handled and laws 
were not followed.23 A major limitation of the Kentucky study was that many records were 
incomplete and lacked enough detail for variable analysis.23 
     Moran et al. conducted a prospective case series study of 2030 animal exposure patient 
presentations at 11 urban university EDs from July 1996 to September 1998.19 Moran et al. 
found, using the 1999 ACIP guidelines, that of 136 PEP treatments, 54 (40%) PEP treatments 
were given inappropriately indicating inappropriate case management.19 Although rabies in 
domestic animals is now rare and 90% of animal rabies in the United States occurs in wildlife, in 
this study dog and cat exposures represented 86% of all PEP given and most of the inappropriate 
PEP.19 Of 60 cases that reported no consultation with local health departments, 16 (27%) of PEP 
treatments were determined inappropriate and of eight cases reporting consultation, two (25%) of 
PEP were inappropriate.19 Moran concluded that the best way to reduce inappropriate PEP is to 
increase the proportion of source animals that are observed and tested. Moran also concluded 
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that medical health providers may immediately administer PEP if they are not confident that the 
animal will be collected.19 
     A Florida study, a retrospective review of 160 PEP patient medical records from 22 county 
health departments (July through September in both 1997 and 1998) randomly selected from 67 
county health departments, revealed that decisions about PEP administration were appropriate 
for 104 of 146 cases (71%), inappropriate for 32 of 146 cases (22%) and 10 of 146 (7%) resulted 
from out of state decisions.5  This study excluded 14/160 (9%) of PEP for missing information 
prior to PEP appropriate analysis.5   Using the 1999 ACIP guidelines, the Florida researchers 
concluded that among 32 cases of inappropriate PEP, 15 PEP cases had no documented rabies 
exposure (possible exposure or touched animal) and 7 cases were exposed to animals that tested 
negative for rabies. Of the 10 remaining cases, 8 PEP were given in lieu of observation and 
testing even though source animals were available and 2 PEP resulted from exposure to low risk 
species.5  Multiple or group exposures resulted in a substantial proportion of inappropriate PEP 
indicating the need for health care providers and public health staff to pay special attention to 
assessment of exposures in these situations.4-5, 22  
     Human rabies is rare in the United States because of effective rabies prevention practices and 
treatment, 53 cases of human rabies have occurred since 1980.1,27-33  In the United States, human 
rabies fatalities occur primarily due to failure to seek effective PEP because of unrecognized or 
unsuspected exposures.33-35 Cryptic cases of rabies, no documentation of rabies exposure even 
with a thorough history, have resulted in the majority of recent human rabies cases in the United 
States.35 According to Messenger, Smith and Rupprecht, since 1958, 63% of 70 cases in 1958-
2001 had no documentation of a bite from a rabid animal.35  Postexposure prophylaxis, including 
all components (wound treatment, HRIG and rabies vaccination), is consistently effective in 
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preventing rabies virus infection mortality if exposure is suspected .3, 35 Two cases of human 
rabies have been reported in Virginia in the last 52 years of reporting. A 29-year-old male 
residing at Nottoway Correctional Center died of insectivorous bat variant rabies in 1998, 
without any history of exposure to the bite or scratch of an animal.33 In 2003, a 25-year-old man 
from northern Virginia died from southeastern raccoon rabies virus variant also without history 
of a potential rabies exposure.30  
     The Centers for Disease Control and Prevention surveillance data indicate that over the last 
one hundred years the principal reservoir hosts for rabies in the United States have changed 
significantly. Prior to 1960 rabies primarily occurred in domestic animals; today 90% of rabies 
occurs in wild carnivores and bats.11 There is an emerging pattern of human rabies deaths 
resulting from bat exposures in the United States.34-35 Since 1990, of 35 cases of human rabies 
indigenous to the United States, 33 (94%) have resulted from bat variant rabies virus.28-33  Some 
bat species appear to transmit rabies more readily than other animal species and assessment of 
bat exposures is particularly problematic.16,34  Specifically two bat species, Lasionycteris 
noctivagans and Pipistrellus subflavus, are linked with rabies virus variants that have accounted 
for more than 70% of human cases and 75% of deaths due to unrecognized exposures in the 
United States.34-35 
     In Virginia the last descriptive study of the epidemiology of human rabies postexposure 
prophylaxis (PEP) was twenty years ago, 1982 -1983.18 A surveillance study with current data on 
PEP patient demographics and types of exposures, circumstances and source animal factors that 
lead to PEP is long overdue in Virginia and is indicated in light of the changing epidemiology of 
rabies, the variable epidemiology between regions of the United States, the emergence of new 
reservoir hosts and recognition of more virulent rabies virus variants.34-36 Evidence-based 
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information about the epidemiology of human rabies PEP in Virginia is necessary to develop 
appropriate education for health care providers, public health practitioners and the public. These 
data should be evaluated with reference to recent and future surveillance data across the United 
States; events in other regions may portend an emerging situation or a future trend in Virginia.35 
Limited supplies of rabies vaccine and HRIG and expensive, unpleasant vaccine regimens 
emphasize the need to evaluate evidence-based data to improve the methods of assessment of 
exposures for appropriate administration of PEP in Virginia. The purpose of this descriptive 
study is to characterize a sample population that received human rabies postexposure prophylaxis 
(PEP) in Virginia as a result of exposures in 2002 and 2003. We specifically want to determine 
the types of exposures and circumstances that resulted in PEP in this sample population. Using 
the 2004 Virginia Rabies Control Guidelines and 1999 Recommendations of the Advisory 
Committee on Immunization Practices (ACIP) guidelines, we will determine to what extent 
rabies postexposure prophylaxis was administered appropriately in Virginia.3,15 
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Objectives 
     The primary objective of this descriptive study is to answer the question “Is human rabies 
postexposure prophylaxis being administered appropriately in Virginia according to the 2004 
Virginia Rabies Control Guidelines and the 1999 Recommendations of the Advisory Committee 
on Immunization Practices (ACIP)?” This study will also characterize the population that 
received human rabies PEP and determine the types of exposures and circumstances of exposure 
that led to human rabies postexposure prophylaxis in Virginia.  
     The results and recommendations from this study will help the Virginia Department of Health 
(VDH) evaluate the administration of PEP in Virginia and target recommendations on 
appropriate PEP administration to health care professionals and public health personnel. The 
information from this study will also help the Virginia Department of Health evaluate current 
PEP data collection methods at Virginia local and district health departments and make 
recommendations for standardization of data collection. The results of this study may have 
application for evaluating human rabies postexposure prophylaxis nationally. 
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Methods 
Definition of Study Sample 
     The data used for this retrospective descriptive study was a convenience sample of patient 
records and animal exposure reports from 838 PEP patients exposed to either potentially rabid or 
rabid animals or humans during calendar years 2002 and 2003. PEP patients included in the 
sample must have begun a course of human rabies postexposure prophylaxis treatment or 
received at least one PEP treatment in Virginia that was reported to a Virginia health district.  
Persons that refused recommended PEP treatment were excluded from this study. All existing 
2002 and 2003 PEP patient and source animal computerized and paper record surveillance data 
(demographics, animal exposure factors, PEP characteristics, and source animal factors) were 
requested from 35 Virginia health districts within 5 regions. Virginia health district directors are 
requested by the Division of Zoonotic and Environmental Epidemiology (DZEE), within the 
central office of the Virginia Department of Health, to annually report aggregate numbers of PEP 
that have been reported to or administered by the local health departments throughout the year. 
PEP reported may be part of the full rabies naïve regimen or the two injection regimen given to 
previously vaccinated persons. For the 2002 study sample, 19 of 35 health districts (54%) 
provided PEP data on 59% (344/586) of PEP cases reported to the DZEE. For the study 2003 
sample, 24 of 35 health districts (69%) provided PEP data on 89% (494/553) of PEP cases 
reported to the DZEE. Expedited Institutional Review Board (IRB) approval was received from 
both Virginia Commonwealth University and Virginia Department of Health (VDH).  
     Existing computerized or paper record PEP data were both reviewed and extracted at the 
Virginia Department of Health offices in Richmond, Virginia or directly at Virginia health 
district offices between August 30, 2004 and December 10, 2004.  PEP patient records included 
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Virginia Department of Health Confidential Morbidity Reports (EPI 1 forms) and patient health 
records from Virginia health departments.  Source animal records included VDH environmental 
health animal exposure reports and locally administered computerized files.  
Definition of Study Variables 
     The outcome variable for this study was human rabies postexposure prophylaxis (PEP), 
administered in Virginia as a result of potential exposure to rabies during calendar years 2002 or 
2003, and reported to Virginia health districts. Included in the analyses were all patients that 
were known to have received at least part of a course of PEP in Virginia, regardless of the 
geographic area in which the exposure occurred.   
     Data were collected in the following categories: demographics, exposure factors, source 
animal factors, and PEP factors.  A data collection instrument was created and utilized as a guide 
for systematic extraction and recording of variables associated with human rabies PEP 
(Appendix A). Data collected on patient demographics included county/city of residence, age, 
gender, race, ethnicity and occupation. Patient exposure factor data included date of exposure, 
county/city, type, circumstance, associated activity, related occupation and anatomical site.  
Source animal factor data included species, availability for observation or testing, date of 
collection, ownership status, rabies vaccination status, behavior and health, exposure to 
confirmed or suspected rabid animal, number of persons and animals exposed to source animal, 
rabies direct fluorescent antibody test results and outcome of confinement and observation of 
source animal. Human rabies PEP factors collected were: date PEP initiated, patient’s previous 
rabies vaccination history, whether PEP was completed, local adverse reactions, general systemic 
adverse reactions, central nervous system reactions, peripheral nervous system reactions and 
immune complex-like reactions. 
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     Several demographic variables were recoded for clarity and to facilitate statistical analyses. 
City/county of residence and exposure were recoded into federal information processing 
standards codes (FIPS codes), a standardized set of numeric codes issued by the National 
Institute of Standards and Technology (NIST) to ensure uniform identification of geographic 
entities through all federal government agencies.37  Virginia health districts were recoded into 
their geographical regions: Northwest, Northern, Southwest, Central and Eastern. Age was 
analyzed as a continuous variable (mean, median, standard deviation, minimum and maximum), 
recoded into 5-year age categories and into child (< 18 years old) and adult (>17 years old) 
categories to calculate age-specific rates of PEP by district and regions based on the 2002 
Virginia population VDH Health Statistics.38   
     Patient exposure and source animal variables were recoded for analyses. Type of exposure 
was recoded into true exposure or not true exposure categories according to rabies exposure 
definitions for appropriate PEP decisions in the 2004 Virginia Rabies Control Guidelines and the 
1999 ACIP recommendations. 3, 15   True exposures were defined using the 2004 Virginia Rabies 
Control Guidelines, “Any bite, scratch or other situation where saliva or central nervous system 
(CNS) tissue of a potentially rabid animal enters an open, fresh wound or comes in contact with a 
mucous membrane by entering the eye, mouth, or nose”, and the 1999 ACIP definitions 
including the recommendations for potential bat exposures, described earlier.3, 15  True exposures 
included bites, saliva on mucous membranes, saliva in an open wound, potential (suspect) bat 
exposures, and exposure to body fluids (where exposure to CNS material or saliva could not be 
ruled out) on mucous membrane or in an open wound. Some districts combined exposures to 
saliva, CNS material, blood, urine and feces into one body fluid category when exposure to saliva 
and/or CNS material could not be ruled out. Not true exposures included exposure to: saliva or 
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body fluids (CNS material, saliva, urine, feces or blood) with no mucous membrane or open 
wound contact; scratches; touching an animal; and secondary exposures. “Secondary exposures” 
refer to exposure to a fomite or animal that had contact with a potentially rabid animal. Multiple 
response variables (type of exposure, anatomical site of exposure and source animal 
behavior/health) were prioritized into a single primary response for analysis. If multiple types of 
exposures were indicated for a PEP patient, then the true exposure (as defined by the 2004 VA 
Rabies Control Guidelines and 1999 ACIP recommendations) became the primary type of 
exposure.3,15  If multiple anatomic sites of exposure were indicated for a PEP patient, then the 
single site closest to the central nervous system (brain, then spinal cord) became the primary 
anatomical site of exposure. Behavior/health categories were collapsed into the following 
primary behavior categories (aggressive, injured, sick, neurological signs, hypersalivation, dead, 
overly friendly and normal). Source animal species were recoded into wild and domestic species 
and high and low risk species (risk for transmission of rabies to humans in Virginia), according 
to the 2004 Virginia Rabies Control Guidelines.15  Domestic animals designated as stray 
indicated no ownership and included feral (breeding in wild) domestic animals.  Confinement 
status was recoded into released normal (domestic dog or cat normal and healthy after ten days 
of observation) or sickened and died (including euthanized, escaped with incomplete 
confinement, and tested positive for rabies during confinement). A captured variable was created 
to include all animals collected for either rabies testing or confinement. Dogs, cats and ferrets 
were recoded into a variable for analysis. An ‘over 2 day’ variable, used for wild species, was 
created to designate rabies test results that would be received after 48 hours of patient exposure. 
A rabies positive variable was created to include source animals that sickened and died during 
confinement as well as animals with positive or unsatisfactory rabies direct fluorescent antibody 
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test results. A group exposure variable was created to characterize PEP patients as part of a 
group exposure (>1 person exposed to 1 animal) or individual exposure (1 person exposed to 1 
animal) and to look at proportions of group and individual exposures that resulted in PEP. 
Appropriateness of PEP 
     To answer the question “Was PEP administered appropriately in Virginia?” we referred to the 
1999 Recommendations of the Advisory Committee on Immunization Practices (ACIP) exposure 
criteria and used Figure 1: The Virginia Department of Health Algorithm for Human Pre- and 
Post- Exposure Treatment in the 2004 Virginia Rabies Control Guidelines.3, 15  PEP resulting 
from human and wolf hybrid exposures were excluded from PEP appropriate analysis because in 
Virginia they are considered on a case-by case basis.  
Statistical Analysis 
     All data collected from existing computer data files and existing paper records of PEP 
patients were entered into a Microsoft Excel file. Personal identifying information was not 
recorded. The human rabies PEP 2002 and 2003 Excel data file was exported to SPSS 12.0. 
Crude and age-specific PEP incidence rates were calculated for districts and regions using MS 
Excel and 2002 Virginia population VDH Health Statistics.38   ArcGIS 9, ESRI GIS Mapping 
and Software was utilized for geographical mapping of crude and age-specific incidence rates by 
region and to show the distribution of districts that provided data by region. Microsoft Excel and 
Microsoft Word were used for graphics and tables. 
     The PEP sample population was characterized by demographic, exposure, source animal and 
human rabies PEP factors by calculating frequencies, percentages and performing cross 
tabulations for 2002, 2003 and both years combined. Total percentages were most representative 
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for description of the PEP study sample because many variables had large percentages of 
unknown or missing information. One rabid human was excluded from source animal analysis.   
      For the appropriateness of PEP analysis, 2003 PEP data was most representative. Data 
collected from 2002 were excluded from analysis because of inconsistencies. In this study, 
several districts had large discrepancies between the number of PEP reported to the DZEE in 
2002 and the number of PEP data provided to the study for that year.  In 2003 several health 
districts began more efficient electronic collection of human rabies PEP data because of the 
implementation of software for environmental health programs to use in their rabies control 
programs. This resulted in more data being stored and made available in 2003 than in 2002.  
     Appropriateness of PEP decisions was determined using SPSS 12.0 to create stepwise syntax 
and a new recoded variable for each key decision pathway (“true exposure?”, “captured?” and 
“rabies positive?”) in the 2004 Virginia Rabies Control Guidelines Algorithm for Postexposure 
Treatment (Figure 1). An objective variable “PEP appropriate?” was built and defined with 
syntax at each level of the PEP decision algorithm and SPSS gathered those PEP that met the 
criteria for appropriateness of PEP to ultimately answer the question, “Was PEP administered 
appropriately?”, for each PEP patient. Differences in the distributions of proportions among 
inappropriate and appropriate PEP by factors were tested using Pearson’s chi-square test for 
proportions and p-values were analyzed at the = 0.05 significance level. 
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Results 
 
Sample Characteristics 
      For this study, 838 PEP patient records were collected and analyzed, 73.6% of 1139 of the 
total PEP reported to the DZEE in 2002 and 2003 (Table 1). The data collection period was 
defined by patient exposures that occurred between January 1, 2002 and December 31, 2003. 
The number and percentages of Virginia health districts that provided data to this study and PEP 
records reported and provided by region for 2002 and 2003 are displayed in Table 1. There were 
inconsistencies between data reported by districts to the DZEE and data provided to the study, 
especially in 2002. Some districts that provided PEP data for a particular year had not reported 
any PEP to the DZEE and others that reported PEP for a particular year did not provide data to 
the study. In 2002, 3 districts (1 each in the Northern, Southwest, and Eastern regions) and for 
2003, 4 districts (1 each in the Northern and Central and 2 in the Eastern regions) neither 
reported data nor provided data to the study. These 7 districts were included as districts not 
providing data to the study in Table 1. In 2002, 54% (19/35), and in 2003, 69% (24/35), of 
Virginia health districts provided data, patient PEP records and animal exposure reports, 
resulting in the study sample of 838 PEP for review. Regions varied by year with respect to the 
proportion of districts that provided PEP data to the study, from 33% (3/9) districts in the Eastern 
in 2002 to 80% (4/5) of districts in the Northern (2003) and Northwest (2002 and 2003) regions. 
Table 1 shows that districts provided records on less than 60% (344/586) of PEP cases reported 
to the DZEE in 2002 (ranging from 43% to 70%), whereas districts provided about 90% 
(494/553) of PEP reported in 2003 (ranging from 73% to 131%). The Eastern region is of 
interest, because it had the lowest district response rates for both years, 3/9 districts provided 
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data in 2002 and 5/9 in 2003, yet for 2003, 31% more PEP cases were provided to the study than 
were reported to the DZEE in 2003. 
     To examine the geographic distribution of PEP provided to this study in 2003, PEP rates for 
those districts that provided data to the study were calculated but are displayed by region for 
reasons of confidentiality (Table 2 and Figures 2a - d). Within regions, the distribution of urban 
versus rural districts that did and did not provide PEP was similar; therefore, we feel that these 
rates can be used to indicate where PEP was administered more frequently (Figure 2a). 
Displayed in Table 2 and Figures 2b – d are the estimated annual crude and age-specific 
incidence rates of PEP by region for the 2003 sample. The crude PEP incidence rate for the 
entire study area was 9.3/105/yr. The PEP rate for children (10.3/105/yr) was 32% higher than for 
adults (7.8/105/yr).  The highest rates of PEP were in the Northwest (15.1/105/yr) region 
followed by the Southwest (12.4/105/yr) and Eastern (10.0/105/yr) regions. Within both the 
Northwest and Southwest regions, the PEP rate for children was 70% greater than the rate for 
adults. The Central and Northern regions, of predominantly urban geography, had the lowest 
rates of PEP, 5.3/105/yr and 6.0/105/yr PEP, respectively. 
Demographic Characteristics 
     Demographic characteristics of those who received PEP are displayed in Table 3. Total 
percentages are presented for those variables with over 5% missing information. The mean and 
median age of the 2002 and 2003 sample was 32.3 and 31.0 years, respectively, with an age 
distribution from 2 months to 97 years. Number and percentage of infant, child and adult PEP by 
age are shown in Table 3. Figure 3, percent PEP and percent 2002 Virginia population by five-
year age categories, displays a bimodal distribution in percent PEP with two age-group peaks 
occurring at 5 – 19 years and 30 – 39 years that do not follow the 2002 Virginia population trend. 
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The proportion of PEP patients steadily increased through childhood from 6.5% for those 0 – 4 
years to peak at 9.4% for 15 – 19 year-olds. During young adulthood (20 – 29 years) PEP 
dropped to about 6.5%, and peaked again to about 9.6% between 30 - 34 years after which there 
was a steady decrease in PEP patients to a low of 1.1% after 65 years. Gender distribution shows 
a slightly greater proportion of females than males received PEP in 2002 and 2003 (Table 3). 
Data on race and ethnicity were missing from 57.4% and 69.9%, respectively, of patient records.  
Exposure Characteristics 
     Animal exposures resulted in PEP throughout every month of both 2002 and 2003 but showed 
a seasonal distribution (Figure 4). PEP numbers increased in the spring and summer months for 
both 2002 and 2003 to peak in July, with a second peak in late fall, primarily because of 
increases in 2003. PEP numbers were lowest in January.   
     Types of exposure that resulted in PEP, categorized as true or not true, are shown in Table 4. 
Total percentages are presented for those variables with over 5% missing information. True 
exposures meet the 2004 VDH Guidelines and the 1999 ACIP recommendations for PEP, “any 
bite, scratch or other situation where saliva or central nervous system tissue of a potentially rabid 
animal enters an open, fresh wound or comes in contact with a mucous membrane by entering 
the eye, mouth, or nose.”15 True exposures, that met the 2004 VDH Guidelines and the 1999 
ACIP recommendations for PEP treatment, resulted in the majority of patient PEP in the study. 
Among 838 PEP exposures, 66.7% (559/838) were categorized as true, 17.8% (149/838) were 
not true and exposure type was unknown for 15.5% (130/838). Table 4 shows that 57% 
(478/838) of PEP resulted from animal bites and 5.5% (46/838) of PEP were from suspect bat 
exposures. There were differences between 2002 and 2003 data with respect to number and 
percentage of PEP resulting from saliva or body fluid on mucous membranes or in open wounds 
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and secondary exposures. Not true exposures (types of exposures that do not require PEP) 
resulted primarily from touching animals, secondary exposures and scratches. Figure 5a shows 
that among 559 PEP that were true exposures, the majority, were due to bites, 85.5% (478/559), 
and suspect bat exposures, 8.2% (46/559). Among 149 PEP that were not true exposures, 31.5% 
(47/149) resulted from touching animals, 26.2% (39/149) from secondary exposures, and 24.2% 
(36/149) from scratches (Figure 5b).  
     Data on both circumstance of exposure and activity leading to exposure were missing from 
over 50% of PEP patient records and the distribution of these exposures by category varied 
between 2002 and 2003. But the available data for these two characteristics shows that the 
primary circumstance leading to exposure and PEP was the victim approaching the source 
animal, resulting in 59.0% (220/373) of PEP. Handling the source animals resulted in 44.6% 
(161/361) of PEP for activity leading to exposure and other activities (exposure to a fomite or 
animal that had contact with a potentially rabid animal or a potential bat exposure) led to 26.0% 
(94/361) of the PEP. In about 21% of both circumstances and activities that led to PEP the source 
animal approached (81/373) or attacked (76/361). Approximately 54% (449/838) of PEP cases 
had data available on primary anatomic site of exposure, and for those data collected, 66.8% 
(300/449), of victims were exposed on the upper limb  (arm, hand, finger or thumb).  
     Overall, individual exposures (1 person to one source animal) represented the majority, 63.6% 
(533/838), of PEP, group exposures (>1 person exposed to one source animal) represented 30.7% 
(257/838) of PEP, and information was missing for 5.7% (48/838) of PEP (Table 4). The 257 
PEP patients with group exposures represented 62 source animals. The group size ranged from 
25 groups of 2 persons to a single group of twenty-three persons exposed. Overall 593 source 
animals exposed 788 PEP patients in the sample (excluding 1 human with rabies).  
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Source Animal Characteristics    
     Table 5 displays characteristics of 593 source animals representing 788 PEP in our sample. 
Total percentages are presented for those variables with over 5% missing information. Among 
571 source animals in the sample, 72.2% (412/571) were domestic species, excluding 1 human, 
primarily cats 50.7% (209/412) and dogs 47.8% (197/412). Wild species represented 27.8% 
(159/571) of the source animals, of those 41.5% (66/159) were raccoons and 27% (43/159) were 
bats. Species information was missing on 3.7% of source animals. Source animals in this study 
were twice as likely not to be captured as captured. About 57% (337/593) of source animals in 
our sample were not captured for observation and/or testing for rabies. For 13.7% (81/593) of the 
source animals, information was missing on capture. Among those captured, 76.5% (130/170) 
were positive for rabies (Table 5). For animals found to be rabies positive, primary behavior 
information was missing on over 50% (70/130). Of those with behavior recorded, aggression was 
seen in 63% (38/60) and 25% (15/60) appeared sick (Table 5).  
     Table 6 displays species of source animal captured by rabies status and number and percent of 
animals and PEP administered. The ratio of PEP to animal is also displayed by rabies status and 
source animal species (Table 6). Among captured animals that tested positive for rabies, 
domestic animals represented 45% (58/129), whereas among captured animals that tested 
negative, 84% (32/38) were domestic. For domestics, 64% (58/90) tested positive. Among cats 
and dogs tested, 77% (44/57) and 40% (12/30) were positive, respectively. Captured wild species 
were more likely to test positive than negative, 92.2% (71/ 77 tested). Overall among animals 
that tested rabies positive, domestic species resulted in more PEP per animal exposure than wild, 
2.8 and 1.7 PEP per animal, respectively. For rabies negative animals, the PEP to animal ratio 
was similar for both domestics and wild, 1.2 and 1.5, respectively (Table 6). 
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     Rabies vaccination status was missing from 88% (361/412) of domestic animals in the study. 
For those 51 animals with data available, 17 were current or had ever been vaccinated.  
Appropriateness of PEP 
     Data from the 2003 sample (n = 494) were analyzed using the 2004 Virginia Rabies Control 
Guidelines Algorithm for Postexposure Treatment (Figure 1) and the 1999 ACIP 
recommendations to determine the appropriateness of PEP decisions. Only 2003 data were 
analyzed because the external and internal validity of the data from 2002 was questioned since 
the numbers of 2002 PEP provided by districts to the study varied markedly from those reported 
to the DZEE in 2002. PEP resulting from human and wolf hybrid exposures (n = 5) were 
excluded from analyses because they are evaluated on a case-by-case basis in Virginia. For the 
2003 sample, PEP was administered appropriately 55.2% (270/489) of the time, inappropriately 
22.5% (110/489) of the time, and appropriateness of PEP could not be determined for 22.3% 
(109/489) of PEP because of missing data (Figure 6).  
     Table 7 compares the number and percent of inappropriate and appropriate PEP by patient 
demographic and exposure characteristics. There were significant differences in the distributions 
of proportions for type of exposure, number in exposure group, and region of exposure. The 
majority of inappropriate PEP, 79% (87/110), resulted from not true exposures (touching 
animals, secondary exposures, scratches and exposure to body fluids with no mucous membrane 
or open wound contact). True exposures resulted in 21% (23/110) of inappropriate PEP because 
of exposures to rabies negative animals.  Most patients that received inappropriate PEP had 
group exposures, 59% (64/110). The proportion of inappropriate PEP was 42% greater for those 
persons with group exposures compared to those with individual exposures. 
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     Table 7 shows that the proportions of inappropriate PEP varied by geographic region of 
exposure. Among the five Virginia regions displayed in Table 7, the proportions of inappropriate 
PEP were highest for the Southwest [36% (39/110)], Northwest [29% (32/110)], and Eastern 
[20.9% (23/110)] regions. The Northwest and Southwest regions had 4 to 5 times greater 
proportions of inappropriate PEP, respectively, than the Northern and Central regions (Figure 
7a). Figure 7b shows that the highest proportions of inappropriate PEP within regions occurred 
in the Northwest [37.6% (32/85)] and Southwest regions [38.6% (39/101)]. 
     For the appropriateness of PEP algorithm analysis, 275 animals represented 379 PEP  
(Table 8). Table 8 compares the number and percent of source animals in the inappropriate and 
appropriate PEP groups (exposed patients that received either inappropriate or appropriate PEP) 
by selected factors. Total percentages are presented for those variables with over 5% missing 
information. Significant differences in the distribution of proportions for appropriate and 
inappropriate PEP were found with respect to the following source animal variables displayed in 
Table 8: domestic or wild species, captured, ownership status and rabies status. More than half of 
the source animals were domestic species for both inappropriate, 56% (33/59), and appropriate 
PEP 77% (166/216) PEP groups. Among inappropriate PEP, 84% (48/57) of animals were 
captured. Among the inappropriate PEP group of animals, 32% (18/56) were owned and 53% 
(26/49) of animals that were captured tested positive for rabies. 
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Discussion and Conclusions 
 
     This study was the first in over twenty years to describe types and circumstances of animal 
exposures as well as source animal characteristics that resulted in administration of PEP and to 
evaluate the appropriateness of human rabies postexposure prophylaxis decisions in Virginia. 
The results of this study provide the Virginia Department of Health a baseline summary of PEP 
surveillance data for 2002 and 2003 on patient demographic, exposure and source animal factors. 
This information will facilitate the evaluation of PEP treatment decisions (past, present and 
future), help target recommendations on appropriate PEP administration to health care 
professionals and public health officials, and help target informational interventions on human 
behavior to prevent rabies exposures.  
     For the overall sample (2002 and 2003), the majority of PEP patients were young (mean 32.3 
years) with the highest risk age groups for exposures and PEP between 5 and 19 years and 30 to 
39 years. Most PEP patients were exposed to source animals in the warmer months of late spring 
and summer when people are often involved in outdoor activities. PEP usually resulted when 
people approached and handled the source animal or had a secondary exposure to fomites or 
animals exposed to the source animal. These preventable circumstances represented 259 PEP in 
this study that could have been avoided. These predominant circumstances of exposure are 
consistent with other PEP studies.4-6,18,23-24   
     The rate of PEP for children was about 30% higher than for adults for the entire geographic 
sample area. Within the predominantly rural Northwest and Southwest regions, the rate for 
children was almost double that of adults. Children may spend more time outdoors and have 
more opportunity to encounter potentially rabid animals in these geographic regions. Health care 
providers may be more inclined to administer PEP to children because of inability to acquire 
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accurate exposure information, parental pressure, or a systematic difference between discernment 
of exposures and treatment decisions between children and adults. The apprehension about rabies 
in children may be higher in different regions of the state because of a higher incidence of animal 
rabies and more opportunities for exposure to wild animals. 
     True exposures, primarily bites (57%), resulted in the majority of PEP in our study. Other 
PEP studies have reported from 16% to 73% of PEP resulted from bites.4-5, 23  Not true exposures 
resulted in 18% of PEP in our study, compared to from 6% to 70%, reported by other 
investigators, for questionable or non-bite exposures.5,18,23-34  
     Capture of source animals and subsequent confinement and/or testing provides information 
essential to appropriate PEP decisions. In this study, 57% of source animals were not captured 
and, therefore, could not be tested for rabies or confined. Capture status was unknown for 
another 14%. If these 418 animals, representing 498 (59%) of the PEP in this study, had been 
captured for testing and/or confinement, much PEP could have been avoided. Although 
identification and capture of all animals may not be feasible, health care providers have a 
responsibility to rapidly notify animal control of exposures to potentially rabid animals to make 
it more likely that the animals are captured.  
     A number of districts provided patient PEP information to the study without matching source 
animal information (animal exposure reports).  Although species and type of exposure were 
indicated on some Confidential Morbidity Reports (EPI 1 forms), animal capture and rabies 
status were not recorded. Capture of source animals is essential not only to determine rabies 
status and appropriateness of PEP, but also to remove a potential source of rabies and prevent 
more exposures. One rural health district director in this study received ED reports of all animal 
exposures and PEP within 24 hours of occurrence and this district was very effective in animal 
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exposure trace backs.  Rabies PEP surveillance and communication between EDs and public 
health departments ideally could be improved through a statewide electronic database linking 
human exposures and PEP treatment information at EDs to source animal information at public 
health departments.  
     Once a person has a true exposure or an exposure to a potentially rabid animal, capturing the 
responsible source animal is the most important factor that can reduce the overall rate of PEP. 
Only after capture can the animal be confined and/or tested to determine rabies status. Domestic 
species represented the majority (72%) of source animals in our study and among the captured 
animals that tested negative in the study, 84% were domestic. This suggests that if all of the 
domestics in the study were captured and tested or confined and observed, much PEP could have 
been avoided. 
     Although 90% of animal rabies reported in Virginia in 2003 occurred in wild species, in this 
sample, wild species represented 55% and domestics 45% of rabid source animals captured.16  
Ninety-two percent of captured wild species in this study were positive for rabies. All raccoons, 
foxes and skunks captured and the majority of bats captured, about 70%, tested positive for 
rabies. Cats were more likely to be positive than dogs, consistent with previous findings.39 
Captured dogs were more likely to test negative. Cats were the most frequently captured 
domestic animal and 77% of cats tested positive in this study. Cats have more opportunity for 
rabies exposure than dogs; they are often free-roaming and unvaccinated. Rabies prevention 
education should emphasize the high likelihood of rabies in all wild species and cats, but should 
also warn the public not to approach any unfamiliar animals. Rabies vaccination of domestic 
dogs and cats continues to be the mainstay for rabies prevention in these species, yet in this study 
many owned cats and dogs were not routinely vaccinated against rabies. 
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     We utilized the 2004 Virginia Rabies Control Guidelines algorithm for PEP decisions and   
the 1999 ACIP recommendations for human rabies postexposure treatment to evaluate exposures 
and appropriateness of PEP decisions.3,15   The 2004 Virginia Rabies Control Guidelines 
recommend that Virginia public health personnel and health care providers use these references 
when evaluating potential rabies exposures and making decisions about PEP.  In the 2003 sample 
of 489 PEP patients, PEP decisions were appropriate for 55% of the patients, inappropriate for 
23% of the patients, and appropriateness of PEP could not be determined for 22% of patients 
because of missing information in records. Moran et al., in a prospective case series of urban 
EDs (Emergency ID Net), also followed an algorithm that was developed based on ACIP 
guidelines to evaluate appropriateness of PEP and found that 40% of PEP was administered 
inappropriately.19  Conti et al. reported 71% appropriate PEP and 22% inappropriate PEP in a 
study that randomly selected Florida county health departments to review PEP records and 
included only those that met specific criteria.5   A 21 state PEP surveillance study by Helmick of 
the newly introduced rabies human diploid cell vaccine in 1980, found that when state health 
departments were involved PEP was given appropriately to 88% of patients.4   
     This retrospective chart review study involved actively collecting PEP data from a passive 
surveillance system. All health districts that provided data to the study within the collection time 
frame were included in the analysis. This resulted in a convenience sample. Missing information 
from all PEP records provided was included in the analysis to supply information on 
completeness of data collection from the districts providing data to the study. By following the 
algorithm we were able to evaluate where data was missing at each stage of the PEP decision 
process. About one fourth of PEP could not be analyzed for appropriateness because of missing 
information on one or more of the three key decision variables: whether the type of exposure was 
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true or not, whether the animal was captured or not, and if the animal rabies status was positive 
or negative. Missing information on type of exposure and source animal rabies status, factors 
necessary to determine appropriateness of PEP, may result in much unnecessary PEP.  However, 
we have no way of knowing if PEP decisions were based only on the information recorded at the 
health departments or if treating physicians obtained other information that did not get entered 
into the health department databases, forms or records reviewed.  More complete and accurate 
data collection on type of exposure, source animal capture and rabies status is essential for health 
care professionals to determine if PEP is appropriate and for follow-up on exposures to 
potentially rabid animals. Public health professionals and health care providers have important 
roles in this process. Open lines of communication between health care providers and public 
health professionals are critical to reporting animal exposures for capture, follow-up 
investigations and for consultation and evaluation of exposures to avoid inappropriate PEP.  
Helmick found that when health care providers consulted with state health departments PEP was 
reduced from five to sevenfold compared to no consultation.4 Careful and detailed history taking 
and documentation in patient medical records as well as in animal exposure reports are essential 
to determine appropriateness of PEP.           
     Not true exposures resulted in the majority (79%) of inappropriate PEP. The first critical step 
in the VDH PEP decision algorithm requires evaluation of the type of exposure, “Did the person 
receive contamination of an open wound or mucous membrane by saliva or brain material from a 
bat, dog, cat, ferret or other terrestrial mammal?” These decisions can be made with knowledge 
of or reference to the 2004 Virginia Rabies Control Guidelines, the 1999 ACIP recommendations 
and, if necessary, consultation with a Virginia Department of Health staff member.  
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     Why did 87 people with not true exposures in this sample receive inappropriate PEP? Several 
possible explanations follow:  1.) The health care provider did not know the definition of a true 
exposure; 2.) the documentation in the patient’s record was incomplete or inaccurate because 
details were omitted; 3.) careful interviewing of the patient did not occur or was not possible in 
the case of a child or mentally challenged person; or 4.) it was unclear whether the rabid animal’s 
body fluids actually contacted an open wound or mucous membrane on the patient. The most 
influential factor leading to inappropriate PEP in our study may have been that over half of the 
captured source animals in the inappropriate PEP group tested positive for rabies, which may 
have made treating physicians and patients more likely to ignore not true exposures. Rabies is 
100% fatal and fear of a highly fatal disease and potential litigation may influence health care 
providers to over treat patients or the patient or minor patient’s parent(s) may have demanded 
treatment. Group exposures represented about 60% of inappropriate PEP in our sample. Helmick 
suggested that group size may be associated with unnecessary PEP and that as the group size 
increased in his study that the proportion of PEP resulting from non-bite exposures increased.4  
     Group exposures represented a greater proportion of inappropriate PEP than individual 
exposures in our sample, although we did not see a trend with increasing group size. 
Psychological forces may be at work among victims of group exposures. Discussions among 
victims may result in exaggeration of exposures and mass panic. The lack of knowledge and 
understanding of what constitutes a true exposure and how rabies is transmitted may result in 
misconceptions about the need for treatment. Health care providers may be subjected to more 
pressure to begin PEP treatment when multiple persons are involved in exposures and exposure 
accounts are not certain or are confused. With group exposures, as in all exposures to potentially 
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rabid animals, it is important for health care providers to interview patients carefully and 
document exposures accurately to avoid unnecessary PEP. 
     The highest proportions of inappropriate PEP and total PEP occurred within the Southwest, 
Northwest, and Eastern regions of Virginia. This may be explained by the rural geography of 
these regions. The overall incidence of animal rabies may be higher in these regions resulting in 
a high perceived threat level and elevated fear of rabies resulting in more inappropriate PEP. 
     This study was limited by the sampling methods used. Human rabies PEP patient data 
collection presents challenges, many in this study were consistent with those previously 
described.5,18,20,23  Our data was collected from a convenience sample, 838 patient PEP records 
voluntarily provided by 24 of 35 Virginia health districts. Although the 24 districts that provided 
data are from various regions and geographic areas, the results may not be representative of the 
entire state.  Health districts provided PEP records that were available, a possible source of 
selection bias. PEP data from health districts that responded may have been systematically 
different (more complete and/or accurate) than data from those not responding.  
     We questioned the external and internal validity of the 2002 sample of data. The 2002 PEP 
sample had inconsistencies within several health districts between the number of PEP passively 
reported to the DZEE in 2002 and the number of PEP records provided to the study. These 
inconsistencies can to some extent be explained by weaknesses of a passive reporting system, 
better data collection in 2003 resulting from the implementation of software for environmental 
health programs to use in their rabies control programs by some districts, and possibly 
redistribution of resources in 2002 in the immediate aftermath of 9/11. For 2002, the district 
response rate for providing data was only 54% compared to 69% for 2003 and the PEP provision 
rate was only 59% in 2002 compared to 89% in 2003.       
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     The type and completeness of data provided varied among districts. The majority of districts 
provided paper records of PEP patient data (75%) that required manual review and interpretation, 
a potential source of information bias.  Information recorded in PEP patient records may have 
been subject to interviewer and recorder bias resulting from the methods of solicitation and 
interpretation by healthcare providers and recall bias from PEP patients’ memory and account of 
exposure circumstances.  Only 25% of the districts sent Excel spreadsheets of aggregate data; 
most of those were missing data on many variables. Because many districts do not link human 
rabies PEP data with source animal exposure data and the locations of these data vary within 
each district, collecting information on all PEP patient variables was problematic. 
Communication with several persons and departments within a health district was often 
necessary to obtain both PEP patient data (EPI-1 forms and patient health records) and source 
animal exposure reports.  For example, animal exposure reports may be collected and stored at 
environmental health offices in some local health departments (LHDs) and health districts or at 
police departments or animal control offices in others. In addition, at many health districts and 
LHDs, there was no standardization for collection of human rabies PEP exposure variables, no 
method in place to link patient rabies PEP and source animal exposure reports, and no 
centralized database to aggregate human rabies PEP data. Districts that used the environmental 
health software provided more complete data, individual computer records, on source animals 
with details on victims and exposures which made linking data easier, although data was not 
aggregated. Standardization and centralization of data collection methods would facilitate more 
efficient and effective surveillance for human rabies PEP. 
     Analysis of appropriateness of PEP and description of many variables were limited by 
missing information from PEP patient files. Due to the amount of missing information from 
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patient PEP records and the variability on types of missing information, we chose to include 
missing information in the analysis and report total percentages to most accurately represent the 
data collected. Variables that had 50% or more missing information in PEP records included 
ethnicity, occupation, whether PEP was completed, circumstance of exposure, activity leading to 
exposure and anatomical site of exposure. Rabies vaccination status and behavior of source 
animals was missing from over 70% of PEP records. We were unable to include information on 
prior PEP patient rabies vaccines or adverse reactions to PEP because this information was 
missing from more than 90% of records.  
     The number of PEP records provided to the study compared to PEP reported to DZEE [74% 
(838/1139)], was better than we expected.  This may be attributed to the active methods 
employed for data gathering in this study, by e-mail and telephone communications. Although 
data extraction was not blinded, we created and adhered to a detailed data collection instrument 
throughout data extraction to help maintain objectivity and consistency.        
     The large number of human rabies PEP treatments reported in Virginia in 2002 and 2003 and 
large numbers of source animals that are not captured suggest that new strategies for education 
of the public, health care providers and public health staff may help reduce these numbers. 
Human rabies PEP treatments are time-consuming, labor intensive, unpleasant for patients and 
carry risk for adverse reactions. PEP treatments are expensive and HRIG and rabies vaccines are 
often in short supply. Based on 1998 estimates for PEP treatment (emergency room, physician 
fees and biologics), we estimate the total direct costs to patients and insurers in Virginia for 110 
cases of inappropriate PEP in 2003 was between $114,000 and $489,000.10 This is an 
underestimate of costs because the 2003 district response rate was 69%, PEP provision rate was 
89%, 22.3% of 2003 PEP could not be analyzed due to missing data and these figures are based 
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on 1998 total treatment costs. Overall, 498 PEP resulting from source animals not captured or 
with unknown capture status in our study cost patients and insurers in Virginia an estimated 
$516,000 to $2.2 million for PEP treatments in 2002 and 2003 combined. Rabies infection in 
humans is 100% fatal but is uncommon in the United States and most rabies cases result from 
unrecognized exposures. No documented human rabies cases have resulted from indirect, 
secondary or non bite exposures.39 Appropriate PEP treatment decisions rely primarily on 
assessing the risks of a true exposure to a rabid or potentially rabid animal, but also on weighing 
the benefits and costs of treatment if the patient was not truly exposed.  
     One approach to reducing the number of PEP resulting from not true exposures and animals 
that are not captured would be the development by health districts of multiple strategies for 
ongoing continuing education of health care professionals, ED personnel, and public health staff 
on the evaluation of animal exposures, the reporting of animal exposures, follow-up on source 
animals and appropriate administration of PEP. Ready access to the 1999 ACIP 
recommendations and 2004 VDH Rabies Control Guidelines definitions of true exposures is 
recommended. Districts may want to recommend that EDs post ACIP guidelines, the current 
VDH Rabies Control Guidelines, and 24 hour contact telephone numbers for LHDs in obvious 
and easily accessible locations. Health care providers should be encouraged to report all 
exposures to potentially rabid animals to the LHD and consult with public health staff in the 
evaluation of difficult PEP decisions. The high turnover of personnel in EDs calls for frequent 
continuing education on rabies prevention and PEP decisions.  Targeting the health care 
providers and LHDs in rural areas of Virginia for continuing education, training and support on 
appropriate assessment of rabies exposures is of particular importance. 
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     The circumstances and activities of human behavior (approaching and touching animals and 
secondary exposures) that led to a great deal of the PEP in this study indicate that much PEP can 
be prevented through public health education. We recommend that public health education on 
rabies prevention continue to emphasize that people not approach, handle or feed any wild 
animals and any unfamiliar, stray or feral domestics, but rather report the animals to animal 
control or authorities. Education about not touching objects or animals that may be contaminated 
with body fluids from a potentially rabid animal and not separating fighting animals is also 
important. Programs and campaigns that target all human populations but particularly those with 
potential outdoor exposures are recommended and possible venues include school health and 
physical education classes, community centers where outdoor sports activities are held, garden 
clubs, hiking clubs, parks and other outdoor related localities and activities.  
     In addition to meeting the purpose and objectives of this study, we have described several 
areas related to human rabies postexposure prophylaxis surveillance and treatment decisions in 
Virginia requiring further research and consideration.  Improvements in the standardization and 
centralization of data collection methods for human rabies PEP in Virginia is recommended to 
facilitate future surveillance activities. The many communications with Virginia health district 
directors and public health personnel involved in human rabies PEP have resulted in increased 
awareness and attentiveness to PEP decisions, record keeping and data collection methods 
throughout many districts in Virginia. As a result of this study, the Director of the Division of 
Zoonotic and Environmental Epidemiology (DZEE) of the Virginia Department of Health 
assembled a work group to address human rabies PEP surveillance. The responsibility of this 
new work group is to develop standard and practical approaches to handling rabies PEP data and 
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follow-up in Virginia. It is the hope of the author that the areas of concern revealed in this study 
will be addressed by the PEP work group.   
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TABLE 1. Virginia Health Districts that Provided Data and PEP Records Provided by Region, 2002 and 2003
2002 2003
Region N N
Northwest 5 4 (80) 129 75 (58) 4 (80) 167 122 (73)
Northern 5 3 (60) 83 58 (70) 4 (80) 89  93 (104)
Southwest 9 5 (56) 128 82 (64) 7 (78) 151 118 (78)
Central 7 4 (57) 84 59 (70) 4 (57) 57  44 (77)
Eastern 9 3 (33) 162 70 (43) 5 (56) 89 117 (131)
Total 35 19 (54) 586 344 (59) 24 (69) 553 494 (89)
Note. PEP = Human Rabies Postexposure Prophylaxis, DZEE = Division of Zoonotic and Environmental Epidemiology
* The 2002 and 2003 sample: n = 838 PEP provided, a response rate of 73.6% of 1139 PEP records reported to DZEE.
N (%)
# PEP 
Reported
to DZEE
# PEP Records
Provided to
Study
N (%)
# VA Districts
Providing Data
to Study
N (%)
# PEP 
Reported
to DZEE
# PEP Records
Provided to
Study
# VA Districts
Providing Data
to Study
N (%)
Total # VA
Health 
Districts 
N
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TABLE 2. Estimated Annual Crude and Age-specific Incidence Rates of PEP by Region, 2003*
 2003 Estimated Annual Rate
Regions [# districts that
provided/# in region (%)]      N
Total PEP
Northwest [4/5 (80%)] 122 810316 15.1
Northern [4/5 (80%)] 93 1555177 6.0
Southwest [7/9 (77.8%)] 118 951561 12.4
Central [4/7 (57%)] 44 829416 5.3
Eastern [5/9 (55%)] 117 1166407 10.0
Total 494 5312877 9.3
Child PEP (<18 years)‡ 
Northwest [4/5 (80%)] 43 202071 21.3
Northern [4/5 (80%)] 22 376182 5.8
Southwest [7/9 (77.8%)] 36 211185 17.0
Central [4/7 (57%)] 11 208114 5.3
Eastern [5/9 (55%)] 22 304672 7.2
Total 134 1302224 10.3
Adult PEP (>17 years)‡
Northwest [4/5 (80%)] 76 608245 12.5
Northern [4/5 (80%)] 57 1178995 4.8
Southwest [7/9 (77.8%)] 73 740376 9.9
Central [4/7 (57%)] 28 621302 4.5
Eastern [5/9 (55%)] 77 861735 8.9
Total 311 4010653 7.8
* 2003 sample: N = 494 PEP from 24 districts that provided PEP.
† Source. Population figures represent those 24 districts providing data to the study and are based on Total 
Virginia Population 2002, Virginia Department of Health, Health Statistics/Statistical Reports and Tables (38).
‡ The 2003 sample had 9.9% (49/494) PEP missing information on age. 
Population†
of PEP
  Rate/100,000
2003 PEP Records
Provided to Study
N
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TABLE 3. Demographic Characteristics of the 2002 and 2003 PEP Samples 
Demographic Variables (N = 838) % (N = 344) % (N = 494) %
Region of Virginia 
   Northwest 197 23.5 75 21.8 122 24.7
   Northern 151 18.0 58 16.9 93 18.8
   Southwest 200 23.9 82 23.8 118 23.9
   Central 103 12.3 59 17.2 44 8.9
   Eastern 187 22.3 70 20.3 117 23.7
Age (years) 
Mean (SD) 32.3 (20.6) 31.2 (19.7) 33 (21.2)
Median (Range) 31.0 (0.2, 97.0) 30.0 (0.2, 85.0) 32.0 (1.0. 97.0)
   Infant (<1) 3 0.4 2 0.6 1 0.2
   Child (1-17) 207 24.7 74 21.5 133 26.9
   Adult (>18) 530 63.2 219 63.7 311 63.0
   Missing* 98 11.7 49 14.2 49 9.9
Gender of Patient 
   Female 412 49.2 163 47.4 249 50.4
   Male 377 45.0 159 46.2 218 44.1
   Missing* 49 5.8 22 6.4 27 5.5
Note. SD = standard deviation 
* Missing information is included for variables with more than 5% missing data. 
Total PEP 2002 PEP 2003 PEP
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TABLE 4. Exposure Characteristics of the 2002 and 2003 PEP Samples 
Exposure Variables (N = 838) % (N = 344) % (N = 494) %
Type of Exposure 
   True Exposure 559 66.7 227 66.0 332 67.2
   Not True Exposure 149 17.8 62 18.0 87 17.6
   Missing* 130 15.5 55 16.0 75 15.2
Type of Exposure Categories
   True Exposure 
   Bite 478 57.0 196 57.0 282 57.1
   Saliva or body fluid on mucous 
     membrane or in open wound 35 4.2 13 3.8 22 4.4
   Suspect Bat 46 5.5 18 5.2 28 5.7
   Subtotal 559 66.7 227 66.0 332 67.2
   Not True Exposure 
   Saliva 19 2.3 10 2.9 9 1.8
   Scratch 36 4.3 17 4.9 19 3.8
   Touching animal 47 5.6 20 5.8 27 5.5
   Body fluid 8 1.0 3 0.9 5 1.0
   Secondary exposure 39 4.7 12 3.5 27 5.5
   Subtotal 149 17.8 62 18.0 87 17.6
   Missing* 130 15.5 55 16.0 75 15.2
Number in Exposure Group 
   1 person 533 63.6 239 69.5 294 59.5
   >1 person 257 30.7 94 27.3 163 33.0
   Missing* 48 5.7 11 3.2 37 7.5
2003 PEPTotal PEP 2002 PEP
* Missing information is included for variables with more than 5% missing data. 
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TABLE 5. Source Animal Characteristics, 2002 and 2003*
N  %
Domestic 412 72.2
Wild 159 27.8
Yes 175 29.5
No 337 56.8
Missing 81 13.7
Yes 130 76.5
No 40 23.5
Aggressive 38 29.2
Sick 15 11.5
Other‡ 7 5.4
Missing 70 53.8
* In the 2002 and 2003 sample, 593 animals were associated with 788 PEP. Excludes 1 human.
Source Animals
† Less than 5% missing information in category. 
‡ Other  is a collapsed category for injured, neurological signs, dead, and overly friendly.
Rabies Positive Among those Captured (N = 175)†
Primary Behavior Exhibited among Rabies Positive Source Animals (N = 130)
Domestic or Wild Source Animal (N = 593)†
Captured for Observation and/or Testing (N = 593)
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TABLE 6. Rabies Status by Species of Animal and PEP Administered, 2002 and 2003 
Captured 
Species N % N % N % N %
Domestic† 
Cat 44 34.1 106 37.6 2.4 13 34.2 16 34.0 1.2
Dog 12 9.3 45 16.0 3.8 18 47.4 18 38.3 1.0
Other 2 1.6 9 3.2 4.5 1 2.6 4 8.5 4.0
Subtotal 58 45.0 160 56.7 2.8 32 84.2 38 80.9 1.2
Wild 
Raccoon 37 28.7 67 23.8 1.8 0 0.0 0 0.0 0.0
Bat 11 8.5 21 7.4 1.9 5 13.2 8 17.0 1.6
Fox 11 8.5 16 5.7 1.5 0 0.0 0 0.0 0.0
Skunk 7 5.4 9 3.2 1.3 0 0.0 0 0.0 0.0
Other 5 3.9 9 3.2 1.8 1 2.6 1 2.1 1.0
Subtotal 71 54.9 122 43.3 1.7 6 15.8 9 19.1 1.5
Total*† 129 100.0 282 100 2.2 38 100.0 47 100 1.2
*Information was missing for 8 captured animals
† Domestic does not include 1 human with rabies
          Rabies Positive Rabies Negative
Animals Tested
Ratio 
PEP:Animal
Ratio 
PEP:Animal
Animals Tested PEP Administered PEP Administered
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TABLE 7. Inappropriate and Appropriate PEP by Patient Demographic and Exposure Characteristics, 2003*†
    Chi
% % % Square p-value‡
Demographic Variables
   Region of Virginia 15.87 0.003
   Northwest 32 29.1 53 19.6 85 22.4
   Northern 9 8.2 46 17.0 55 14.5
   Southwest 39 35.5 62 23.0 101 26.6
   Central 7 6.4 31 11.5 38 10.0
   Eastern 23 20.9 78 28.9 101 26.6
Exposure Variables
   Type of Exposure 276.95 <0.001
   True 23 20.9 270 100.0 293 77.1
   Not True 87 79.1  -  - 87 22.9
   Number in Exposure Group§ 32.87 <0.001
   1 person 45 41.3 196 72.6 241 63.4
   >1 person 64 58.7 74 27.4 138 36.3
* Excluded 2 PEP resulting from human exposures and 3 PEP from wolf hybrid exposures.
† 2003 Sample analyzed for appropriateness of PEP  380/489 = 77.7% :  Appropriate PEP = 270/489 =  55.2%,
Innappropriate PEP 110/489 =  22.5%, Missing information 109/489 = 22.3%. 
‡ p - values calculated from Pearson chi square test of proportions, analyzed at α = 0.05 significance level.
§ Less than 5% missing in category.
(N = 110) (N = 270) (N = 380)
  Inappropriate PEP Appropriate PEP        Total PEP
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TABLE 8. Comparison of Source Animals in Inappropriate and Appropriate PEP Groups
                  by Source Animal Characteristics, 2003*†
Source Animal Characteristics    %   %
Domestic or Wild Source Animal 10.1 0.001
Domestic 33 55.9 166 76.9 199
Wild 26 44.1 50 23.1 76
Captured for Observation and/or Test‡ 90.9 <0.001
Yes 48 84.2 39 18.1 87
No 9 15.8 177 81.9 186
Ownership status 28.7 <0.001
Owned 18 32.1 24 11.1 42
Stray or Feral 12 21.4 117 54.2 129
Wild 26 46.4 50 23.1 76
Missing 3 5.0 25 11.6 28
Rabies Positive (of those captured) 25.3 <0.001
Yes 26 53.1 40 100.0 66
No 23 46.9  -  - 23
Missing 10 16.9 176 81.0 186
* Does not include 1 human and 1 wolf hybrid. 
† 275 animals represented 379 PEP analyzed for appropriateness of PEP.
‡ Less than 5% missing information in category. 
§ p - values calculated from chi square test of proportions, analyzed at α = 0.05 significance level.
 Chi 
Square
p-value§
Source Animals 
(N = 59) (N = 216) (N = 275)
Inappropriate PEP Appropriate PEP Total
 
 
                  
  
   
 46
 
 
 
 
 
 
 
 
 
 
FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
  
  
  
 47
FIGURE 1. Algorithm: Human Rabies Postexposure Treatment 
 
RABIES 
 
 Did the person receive contamination of an 
 open wound or mucous membrane by saliva          No 
 or brain material from a bat, dog, cat, ferret,  
 or other terrestrial mammal? 
 
 Yes         No Postexposure 
         Prophylaxis Necessary 
 
  
 Did consultation with local or state health  No 
 authorities indicate a risk of rabies in the   
 species in the geographical area? 
 
  Yes 
 
 
   Begin Postexposure No   Was the animal captured? 
         Prophylaxis 
   Yes 
    
 
Will it take longer than 48 hours        No  Was the animal a dog, cat, or ferret? 
       to get test results?  Yes 
  No   
   Did the dog, cat, or ferret sicken 
       Was rabies confirmed by direct  or die with signs of rabies within 
   Yes    fluorescent antibody testing of the  the 10-day observation period 
              animal brain? after the exposure? 
 
   No 
   Begin Postexposure  Yes   
          Prophylaxis No 
   Yes  
          No Postexposure Prophylaxis 
                  Necessary 
                 Discontinue Postexposure 
                                      Prophylaxis                                  Begin/Finish Postexposure 
                                                                                     Prophylaxis  
   
 
 
Source: 2004 Virginia Rabies Control Guidelines, Virginia Department of Health (15) 
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         FIGURE 2a. Health Districts that Provided PEP Data, 2003 
 
             
 49
                                                                                    
                  
                  
         FIGURE 2b. Crude Incidence Rates of PEP by Region, 2003*
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         FIGURE 2c. PEP Incidence Rates for Children by Region, 2003*
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         FIGURE 2d. PEP Incidence Rates for Adults by Region, 2003* 
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*5-year age information available for N = 614 PEP (26.6%, 224/838 PEP missing data) 
  Source: VDH. Total Virginia Population 2002, Health Statistics/Statistical Reports and Tables (38) 
FIGURE 3. Percent PEP and 2002 Virginia Population by 
 5-year Age Groups, 2002 and 2003*
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 FIGURE 4. PEP by Month of Exposure, 2002 and 2003* 
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                                   * Month of exposure available for N = 741 PEP (11.6% (97/838) PEP missing data) 
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*True Exposures: N = 559 PEP 
  Body fluid – Indicated when an exposure to saliva and/or CNS material could not be ruled out.
FIGURE 5a. True Exposures 
Percent PEP by Type of Exposure 
 2002 and 2003*
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* Not True Exposures: N = 149 
FIGURE 5b. Not True Exposures 
Percent PEP by Type of Exposure 
 2002 and 2003*
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26.2
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Touching animal
Secondary exposure
Scratch
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             FIGURE 6. Flowchart for 2003 Appropriateness of PEP Algorithm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               * Excludes 2 PEP from human exposures, and 3 PEP from wolf hybrid exposures
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* The 2003 sample: N = 380 PEP analyzed for appropriateness of PEP 
 
FIGURE 7a. Percent Appropriate and Inappropriate PEP among Regions, 2003* 
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FIGURE 7b. Percent Appropriate and Inappropriate PEP by Region, 2003*
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* The 2003 sample: N = 380 PEP analyzed for appropriateness of PEP
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Appendix A. Data Collection Instrument 
The Epidemiology of Human Rabies Postexposure Prophylaxis (PEP) 
in Virginia, 2002 and 2003 
 
I. Rabies Postexposure Prophylaxis (PEP) 
 
1.  Date PEP initiated:___________________________Month , Day, Year (00-00-00) 
 
2.  Rabies Vaccination Status 
   1. Never vaccinated (Never) 
   2. Pre-exposure vaccinated (Pre-exp) 
   3. Previous PEP (PrevPEP) 
   4. Unknown 
 
3. PEP completed?    
1. Yes    
2. No  
3. Unknown 
  
4. Local Adverse Reactions (injection site reactions)?  
   1. Pain 
   2. Erythema 
   3. Swelling 
   4. Itching 
   5. Bruise 
   6. Unknown = not reported 
 
      5. General Systemic Adverse Reactions? 
   1. Headache 
   2. Nausea 
   3. Abdominal pain 
   4. Vomiting 
   5. Muscle aches 
   6. Dizziness 
   7. Sweat 
   8. Anxious 
   9. Dyspnea 
   10. Unknown = not reported 
 
     6. Central Nervous System Reactions____________________________________________ 
________________________________________________________________________ 
 
     7. Peripheral Nervous System Reactions  _________________________________________ 
 _______________________________________________________________________ 
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     8. Immune Complex-like Reactions 
   1. Generalized urticaria 
   2. Arthralgia 
   3. Arthritis 
   4. Angioedema 
   5. Nausea 
   6. Vomiting 
   7. Fever 
   8. Malaise 
   9. Other___________________________________________ 
   10. Unknown 
 
II. Human PEP Patient Demographic Data 
 
1. County/city of residence:_________________________________________________ 
 
2.   Age___ (if numerical age not given then indicate adult or child) 
 
3.   Gender   
1. Female 
   2. Male 
 3. Unknown 
 
      4. Race   
 1. White (Caucasian) 
 2. Black (African-American) 
 3. American Indian or Alaskan Native 
 4. Native Hawaiian or Pacific Islander 
 5. Asian 
 6. Other  
   7. Unknown 
       5. Ethnicity 
   1. Hispanic (Hispanic) 
   2. Non-Hispanic (Non) 
 
       6. Occupation: 
1. None 
2. NA – child 
3. Unemployed 
4. Retired 
5. Disabled 
6. Veterinarian 
7. Vet. Staff (Vet. Assistant, or Vet. Tech) 
8. Wildlife Rehabilitator 
9. Animal Control/Caretaker 
10. Other 
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III.  Rabies Exposure Factors and Circumstances of Exposure for person receiving PEP 
 
1. Date of exposure: ______________________________Month, Day, Year (00/ 00/ 00) 
 
2. County/City of exposure: _________________________________________________ 
 
3. Anatomical site of exposure: (Circle all that apply) 
1. Head/neck (to include face) 
2. Arm/hand (to include wrist, shoulder) 
3. Leg/foot (to include ankle) 
4. Torso 
5. Potential Bat Contact (PotBat) no anatomical site recognized 
6. Unknown (anatomical site not known) 
 
4. Type of exposure: (Circle all that apply) 
1. Single bite (Bite) 
2. Multiple bites (Multbites) 
3. Scratch with unknown contamination (Scratch) 
4. Scratch with Saliva contamination (Scratch/Sal) 
5. Scratch with central nervous system (CNS) tissue contamination 
(Scratch/CNS) 
6. Open Wound with Saliva contamination (Wound/Sal) 
7. Open Wound with CNS tissue contamination (Wound/CNS) 
8. Saliva on mucous membrane (Sal/mm) saliva on eye, mouth, nose 
9. CNS tissue on mucous membrane (CNS/mm) 
10. Touching animal (Touchani) = except bats and assuming no saliva 
on mm or in wound 
11. Skinning/dressing animal (Skinning) 
12. Potential Bat Contact (PotBat) = handled (direct contact) or in 
room or vehicle with bat 
13. Secondary Exposure (secondexp) = exposed to animal or fomite 
with saliva contamination 
14. Blood (no mm or wound contact) 
15. Saliva (no mm or wound contact) 
16. Body Fluid (BodyFluid) = Blood, Urine, Feces, Saliva no 
distinction made (no mm or wound contact) 
17. Unknown 
 
5. Circumstances of exposure: 
1. Person approached animal (persappr) 
2. Animal approached person (animappr) 
3. Potential Bat Contact (PotBat) = Bat in house etc, unrecog. Exp. 
4.   Secondary Exposure = saliva on fomites, potential exposure to  
saliva from source animal on victim’s pet or other animal 
5. Unknown 
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6. Occupation-related exposure? (Exposure occurred at work and occupation may or may 
not be directly associated with animals.) 
1. Yes 
2. No 
3. Unknown 
 
7. Person’s activity leading to exposure: 
1. Handling (handling) = includes petting, caring for (giving shots) 
2. Playing with animal (playwi) 
3. Picking up animal (pickup) 
4. Feeding animal (feedanim) 
5. Skinning/dissecting animal (skinning) 
6. Eating animal (eatingani) 
7. Attacked by animal (attbyani) 
8. Separating fighting animals (sepfiani) 
9. Kissing animal (kissanim) 
11. Other = contact with source animal’s saliva on fomites or on 
animal exposed to source animal; potential bat exposure (bat in house 
or vehicle or direct contact) 
12. Unknown 
 
IV.  Source Animal Factors 
 
1. Species 
1. Raccoon 
2. Skunk 
3. Fox 
4. Bat  
5. Cat 
6. Dog 
7. woodchuck  (groundhog) 
8. beaver 
9. Opossum 
10. Rat 
11. Horse 
12. Bovine – Cattle 
13. Captive wild species_____________________________________ 
14. Wild hybrid = Wolf Hybrid 
15. Unknown 
  
2. Available for observation and testing? 
1. Yes 
2. No (notavail) 
3. Unknown 
 
3. Date animal collected_____ Month/ Day/ Year, or  Not Available (NotAvail) 
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4. Animal Ownership  
1. Stray  (includes feral = born in wild) 
2. Owned (domestic species) 
3. Wild animal in wild (wild) 
4. Captive wild species 
5. Unknown 
 
5. Animal has vaccination against rabies? 
1. Yes current (current) 
2. Yes - not current (expired) 
3. No – no vaccines 
4. Unknown 
5. NA = wildlife  
 
6. Animal behavior/health at time of exposure, collection or confinement 
1. Dead 
2. Normal 
3. Abnormal 
4. Unknown 
 
          Circle any one or more that apply about animal behavior at capture: 
1. Sick 
2. Aggressive 
3. Overly friendly (ovfr) 
4. Wobbly gait or other neurological signs (neurol) 
5. Paralyzed 
6. Injured 
7. Other_______________________________ 
 
     7.  Was source animal known to be exposed to a confirmed rabid animal? 
         1. Yes 
         2. No 
         3. Unknown 
 
      8. Was source animal known to be exposed to a suspect rabid animal? 
         1. Yes 
         2. No 
         3. Unknown 
      
       9. Number of persons exposed to source animal: ___________________________________ 
 
     10. Number of domestic animals exposed to source animal: __________________________ 
 
 
 
 
       
  
  
  
 65
 
     11.  Laboratory test results for rabies virus in source animal: 
1. Positive 
2. Negative 
3. Unsatisfactory specimen (unsat) = indeterminate 
4. Not submitted (notsub) = either unavailable for testing because 
animal at-large or released from confinement/quarantine in negative 
status 
5. Unknown = not reported 
 
     12. Confinement and Observation (dogs, cats, ferrets and livestock) 
1. Confinement period completed, animal released normal (Conf/Rel) 
2. Abnormal behavior during confinement – Test Positive (Conf/Pos) 
3. Abnormal behavior during confinement – Euthanized (Conf/Euth) 
4. Confined – no follow-up (conf/inc) 
5. Not Available for confinement = animal at-large (notavail) 
6. Not Applicable (NA) – (wild species, collected and tested positive) 
 
     13. Followed ACIP Recommendation for rabies postexposure prophylaxis  
1. Yes  
2. No = no documentation of saliva or CNS contamination 
to open wounds or mucous membranes (eyes, nose, mouth) 
Ex.: handling, picking up, petting, scratch, blood 
3. Unknown = could be in accordance with ACIP 
recommendations but unable to determine from information given.  
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